Biodesix Inc logo

Biodesix Inc

$ 2.56 -0.09 (-3.4%) 11:03 AM EST
P/E:
At Loss
P/B:
13.50
Market Cap:
$ 103.64M
Enterprise V:
$ 106.95M
Volume:
13.04K
Avg Vol (2M):
153.95K
Volume:
13.04K
Market Cap $:
103.64M
PE Ratio:
At Loss
Avg Vol (2-Month):
153.95K
Enterprise Value $:
106.95M
PB Ratio:
13.50
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Biodesix Inc
NAICS : 541380 SIC : 8734
2970 Wilderness Place, Suite 100, Boulder, CO, USA, 80301
Compare
Compare
AWH TRIB STIM SERA CNTG AKU CHEK PMD TTOO XGN TMO DHR XSWX:LONN SHSE:603259 IQV ILMN A IDXX MTD LH
Traded in other countries / regions
BDSX.USA
Description
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Name Current Vs Industry Vs History
Cash-To-Debt 0.96
Equity-to-Asset 0.1
Debt-to-Equity 3.21
Debt-to-EBITDA -0.53
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.05
Distress
Grey
Safe
Beneish M-Score -2.93
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 57.91
9-Day RSI 61.35
14-Day RSI 62.63
6-1 Month Momentum % -45.98
12-1 Month Momentum % -74.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.06
Quick Ratio 1.06
Cash Ratio 0.71
Days Sales Outstanding 48.93
Days Payable 48.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.6
Name Current Vs Industry Vs History
Gross Margin % 60.23
Operating Margin % -162.47
Net Margin % -179.84
ROE % -365.05
ROA % -69.43
ROIC % -89.55
ROC (Joel Greenblatt) % -969.49
ROCE % -94.25

Financials (Next Earnings Date:2022-11-15 Est.)

BDSX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:BDSX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 31.253
EPS (TTM) ($) -1.8
Beta 0
Volatility % 60.71
14-Day RSI 62.63
14-Day ATR ($) 0.25449
20-Day SMA ($) 2.34925
12-1 Month Momentum % -74.77
52-Week Range ($) 1.25 - 10.22
Shares Outstanding (Mil) 39.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biodesix Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More